Baldev Ahluwalia

Executive / GM Healthcare Product and Portfolio Development

Role: Senior Executive Consultant, Commercialization and Product Management at Endra Life Sciences Nasdaq Ndra
Location: Waukesha, WI, US
LinkedIn followers: 500 followers

General Business & ManagementView LinkedIn profile

About Baldev Ahluwalia

Passionate for creating solutions that improve patient care, reduce healthcare costs, and…

Experience

Senior Executive Consultant, Commercialization and Product Management
Endra Life Sciences Nasdaq Ndra
Oct 2023 — Present · Ann Arbor, WI, US

Education

Brock University
Physics
Western University
Medical Biophysics

Skills

Pacs
Mri
Cross-Functional Team Leadership
Medical Imaging
Medical Devices
Product Development
Radiology

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
•••••@endrainc.com
Personal email
•••••@•••••.com
Direct dial
+•• ••• ••• ••••

Unlock verified contacts

Free to start · No credit card required

Current company

Endra Life Sciences Nasdaq Ndra

Medical Equipment Manufacturing · 18 employees · Ann Arbor, Michigan, United States

ENDRA Life Sciences Inc.(\"ENDRA\")(NASDAQ: NDRA) is a developer of enhanced ultrasound technologies. ENDRA is developing a next generation Thermo-Acoustic Enhanced UltraSound (TAEUS™) platform to enable clinicians to visualize human tissue composition, function and temperature in ways previously possible only with CT & MRI - at a fraction of the cost, and at the point-of-care. ENDRA\'s first TAEUS application will focus on the quantification of fat in the liver, for early detection and monitoring of Non-Alcoholic Fatty Liver Disease (NAFLD). ENDRA\'s goal is to bring new capabilities to ultrasound - thereby broadening access to better healthcare. For more information, please visit Non-Alcoholic Fatty Liver Disease (NAFLD) is a condition closely associated with obesity, diabetes, hepatitis-C and certain genetic predispositions in which fat accumulates in the liver. NAFLD affects over 1 billion people globally and is estimated to cost the U.S healthcare system over $100B annually. NAFLD is often asymptomatic and, If left untreated, NAFLD can progress to inflammation (NASH), tissue scarring (fibrosis), cell death (cirrhosis) and liver cancer. By 2025, NAFLD is forecast to be the greatest root cause of liver transplants. The only tools currently available for diagnosing and monitoring NAFLD are impractical: expensive Magnetic Resonance Imaging (MRI) or an invasive surgical biopsy.

endrainc.com

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

About Baldev Ahluwalia

Experience

Senior Executive Consultant, Commercialization and Product Management

Education

Brock University

Western University

Skills

Find verified contacts for anyone on LinkedIn